Wednesday is going to mark yet another important day for the early wave of key earnings for this earnings season. The second quarter became more challenging for many companies as we noted…
News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment has the entire drug sector up in arms as it pertains to…
Health care products maker Abbott Laboratories (NYSE: ABT) received US Food and Drug Administration approval to market its new glucose monitoring system for the nearly 26 million US diabetics who take insulin.…
Paul Ausick Abbott Laboratories (NYSE: ABT) may be in the midst of a long-term restructuring, but the company turned in earnings growth of 11.5% to $1.45 EPS. The analyst consensus estimate was $1.44 per…
Jon C. Ogg Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that fourth-quarter revenue from its Provenge prostate-cancer vaccine would exceed earlier forecasts. Looking…
It’s that time of year again, when proxies are released and many business publications run lists of the highest paid CEOs at America’s large public companies. The compensation figures are extraordinarily high,…
Stocks opened down this morning following the earnings report Apple Inc. (NASDAQ: AAPL) after markets closed yesterday. Moody’s downgrade of Spain’s sovereign debt also weighed on the opening. The Consumer Price Index for…
Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public. So what about when a company decides to unlock shareholder value by breaking itself…
MSNBC: US housing starts jumped in September http://on.msnbc.com/pxVyNE NYT: Olympus Backtracks on Payments http://nyti.ms/pAPNmD CNNMoney: Apple 2.0: Apple’s big miss: The analysts weigh in http://bit.ly/r7OZMN $AAPL FT: Olympus contradicts chairman over fees…
With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there are companies that have already proven themselves in the recent recession. They…
Medical device maker Boston Scientific Corp. (NYSE: BSX) has named a new president who will take over on October 17th and who will then be elevated to CEO on November 1, 2012.…
Implanted medical devices are one of the most profitable businesses of the U.S. healthcare industry. While many devices help extend and improve quality of life, a great many others may not be…
Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key drugs go off-patent and there will be new generic competition. While this…
Google (NASDAQ: GOOG) was sued by PayPal and Ebay (NASDAQ: EBAY) over the use of trade secrets in its new e-commerce payment system. (Reuters) A power shortage in China may cause the…
It is almost every day that we take a look at the market capitalization rates of some of America’s largest public companies in our own Real-Time 500 reading. The recession killed many stocks…
